Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics 
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Home » Signaling Pathways » mTOR Signaling Pathway
ERK1/2
Insulin
Receptor Growth
Factor
Receptor p53 PKCα PDK1 Akt p90 RSK p70 S6K Wnt AMPK GSK-3 PPARγ PP2A Autophagy Rapamycin Angiogenesis mTOR mTOR PI3K
Receptor Growth
Factor
Receptor p53 PKCα PDK1 Akt p90 RSK p70 S6K Wnt AMPK GSK-3 PPARγ PP2A Autophagy Rapamycin Angiogenesis mTOR mTOR PI3K
mTOR (mammalian target of Rapamycin) integrates signals both intrcellularly and extracellularly to regulate growth, proliferation, metabolism and survival. It can form two complexes within the cell, known as mTORC1 and mTORC2 which are dependent on their regulatory proteins Raptor and Rictor respectively. mTOR is important for both the Akt and insulin signal transduction pathways and is deregulated in cancer and Type 2 diabetes.
Questions? Comments? Leave feedback.
